2024-09-24 - Analysis Report
## HCA Healthcare Inc (HCA) Stock Analysis Report

This report provides a comprehensive analysis of HCA Healthcare Inc (HCA) stock, encompassing its performance against the S&P 500, recent price trends, technical indicators, and financial performance.

**1. Performance vs. S&P 500 (VOO)**

HCA Healthcare Inc is a leading healthcare provider operating in the United States. 

**Cumulative Return:**

* HCA: 335.4
* S&P 500 (VOO): 133.1

**Divergence:**

* Max: 202.3
* Min: -22.96
* Current: 202.3
* Relative Divergence: 99.55 

HCA has significantly outperformed the S&P 500, with a current cumulative return divergence of 202.3, placing it at the 99.55th percentile of its historical performance range relative to the S&P 500.

**2. Recent Price Trends**

* Closing Price: 405.7
* 5-day Moving Average: 401.88
* 20-day Moving Average: 394.61
* 60-day Moving Average: 362.18

HCA's price has been trending upwards recently, with the stock trading above its 5, 20, and 60-day moving averages. This suggests a strong bullish sentiment in the short to medium term.

**3. Technical Indicators**

* RSI: 60.52
* PPO: -0.08
* Delta_Previous_Relative_Divergence: -0.45
* Expected Return: 0.91%

The RSI (Relative Strength Index) indicates that HCA is currently in the overbought territory, suggesting a potential correction in the short term. However, the PPO (Percentage Price Oscillator) value suggests a slight downward trend, indicating some selling pressure. The recent relative divergence suggests a short-term downward trend. The Expected Return of 0.91% reflects the potential for a positive return on investment over the next 5 years.

**4. Recent Earnings and Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | 17.49 B$ |
| 2024-05-02 | 6.01 | 17.34 B$ |
| 2023-10-26 | 3.98 | 16.21 B$ |
| 2023-08-02 | 4.35 | 15.86 B$ |
| 2024-07-29 | 4.35 | 15.86 B$ |

HCA has consistently delivered strong earnings growth, with the most recent quarter's earnings exceeding analyst expectations. The company's revenue has also been steadily increasing, indicating robust growth in the healthcare industry. 

**5. Overall Analysis**

HCA has demonstrated strong performance, outperforming the S&P 500 by a significant margin. Recent price trends suggest a positive outlook, although the stock may be in overbought territory according to RSI. The company's strong earnings and revenue growth provide a solid foundation for future performance.

**6. Conclusion**

HCA Healthcare Inc presents a compelling investment opportunity for investors seeking exposure to the healthcare sector. The company's strong historical performance, positive price trends, and solid earnings make it a strong contender for long-term growth. While the stock may be in overbought territory, its overall fundamentals remain strong.

**Disclaimer:** This report is for informational purposes only and should not be considered investment advice.  It's essential to conduct thorough research and consult with a financial advisor before making any investment decisions. 
